Seward moves to new premises

Published: 3-Feb-2011
Manufacturing Active Nutrition Food

Doubles manufacturing and storage facilities

Seward Ltd, the manufacturer and developer of the Stomacher laboratory paddle blender range, has moved to new premises in Worthing, UK, which will double the firm’s manufacturing and storage facilities.

The new building represents a significant investment by the company following the securing of a NatWest/RBS Manufacturing Fund. It will also ensure shorter lead times for the Stomacher sample preparation products for microbiological analyses and tissue processing, the company said.

The premises also house a purpose-built r&d laboratory for product development, application assessment and customer protocol development.

Further investment in web conferencing facilities will also allow training webinars and in-depth technical support to be offered to customers, wherever they are located.

The new premises support a much-needed increase in production capacity, driven by new applications and the opening of Seward Inc in Long Island, New York, US in 2009.

In the first half of 2010, sales of the Stomacher laboratory blenders grew by nearly 20%, compared with the same period in 2009. Sales of the Stomacher 80 biomaster range for small tissue processing increased by 53%, while the large volume Stomacher 3500 saw a 72% growth.

‘We are dedicated to maintaining excellence in our products, customer service and support for our rapidly growing global customer base, so the increased size and capacity of our new premises ensures we can guarantee this now and in the future,’ said Stuart Ray, technical director, Seward Ltd.

He added that the firm had also seen strong growth in the US and Asia/Pacific regions.

See more

You may also like

Manufacturing

Seward simplifies cell preparation

Read more
Enhances applications for Strainer bags to include sterile processing of tissue samples

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    Overcoming the hurdles of strategic market expansion Ramprasad Kaparaboyena, Regulatory Affairs Manager and QP for Pharmacovigilance at Gaelic Laboratories, discusses how to overcome the challenges of expanding your pharma market into new global regions
  2. Vetter Pharma to build new manufacturing site in Germany as part of €1.5bn global expansion plan The company has submitted a building permit application for a new commercial manufacturing facility in Saarland, Germany, with construction set to begin in Q2 2026 and operations planned for 2031
  3. Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
  4. LabIndex - Sourcing solutions powered by a network of world-class suppliers Labtex states: "Using our experience and negotiating power, we can speedily source and procure virtually any type of laboratory equipment or consumables at competitive prices."
  5. New thermal inkjet printer expands AM Labels’ coding portfolio M2 system delivers high resolution variable data printing at production-line speeds

Upcoming event

High Shear = Mixing Success

19 February 2026 | Virtual See all

You may also like

Manufacturing

Seward simplifies cell preparation

Enhances applications for Strainer bags to include sterile processing of tissue samples
Manufacturing

Bracco enters cell therapy manufacturing with microbubble-based cell selection technology

Bracco Imaging is expanding into cell therapy manufacturing with a bead-free cell selection and activation technology based on its clinically validated microbubble platform
Manufacturing

New manufacturing line from Adragos granted regulatory approval from Swissmedic

The approval of the new, state-of-the-art facility follows a comprehensive modernisation programme in 2024/2025 that has focussed on ensuring the future-readiness of the plant
Manufacturing

Freudenberg Medical launches new hydrophilic coating LUBRITEQ

The launch comes alongside a comprehensive suite of associated development and manufacturing services designed to remove commercial barriers and enable long-term, trust-based partnerships
Manufacturing

The REACTEX range - cutting-edge components, unmatched precision

Utilising cutting-edge components from leading UK and German manufacturers, the REACTEX range of interchangeable glass reactors offer the following:
Manufacturing

Drug-loaded pellets: unlocking flexible oral dosage design with modern pelletisation technologies

Produced using advanced extrusion–spheronisation technologies such as GEA’s NICA systems, drug-loaded pellets are gaining traction as a flexible and scalable oral solid dosage platform that enhances release control, patient outcomes and manufacturing efficiency
Manufacturing

Vetter Pharma to build new manufacturing site in Germany as part of €1.5bn global expansion plan

The company has submitted a building permit application for a new commercial manufacturing facility in Saarland, Germany, with construction set to begin in Q2 2026 and operations planned for 2031
Subscribe now